𝔖 Bobbio Scriptorium
✦   LIBER   ✦

O-3 Long-term results from the ZEBRA trial comparing Goserelin with CMF as adjuvant therapy in premenopausal women

✍ Scribed by M. Kaufmann; W. Jonat; W. Sauerbrei; R. Blamey; M. Schumacher; for the Zoladex Early Breast Cancer Research Association (ZEBRA)


Book ID
118625959
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
162 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.